JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1219605, encodeId=5ae912196054d, content=偏重的研究方向：肿瘤 经验分享：请问各位大神，这篇杂志投meta分析的话需要注册号吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e130109651, createdName=minni, createdTime=Sat May 14 16:11:07 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217427, encodeId=7d5f121e42755, content=求教：第一次投稿，小白一个，请问点击提交手稿后提示“'Submit a Manuscript' is not available for this publication.”，还是我投的地方不对，请赐教，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80564692906, createdName=945590468, createdTime=Fri May 06 20:49:27 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586545, encodeId=12ab5865454a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：写的一篇meta分析，2019年12月26日投稿，2020年1月15日一审审回，送了一个审稿人，提了一个相对容易点的问题，编辑给了大修。然后因为疫情耽搁了一个多月，最终在3月6号修回，第二天就送审了，3月10号收到接收信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/2686ccce883b2b8223b954905ff32d1e.jpg, createdBy=8f352558772, createdName=Ultraviolet, createdTime=Fri Mar 13 20:40:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212690, encodeId=6a6d121269005, content=能麻烦问一下这个提交的格式么还有这个期刊算sm a l l size journal 还是large 参考文献用什么格式呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7db88111196, createdName=ms6000001992460971, createdTime=Tue Apr 19 22:16:08 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212726, encodeId=581d1212e26e5, content=请问在哪里看目前有多少文章 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99298116595, createdName=ms5000000202400576, createdTime=Wed Apr 20 01:27:48 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209566, encodeId=d64e120956675, content=请问大佬们，为什么我的稿件投出去被秒退，我按照了guidline的操作，正文word，补充文件PDF，还没有到编辑那里就被退了…哭了…求教大佬……呜呜呜……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07b06478899, createdName=ms8000000732418295, createdTime=Fri Apr 08 14:43:40 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015523, encodeId=ddce1015523c2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：经验分享：这是我第一篇SCI，终于接收，想写一个分享帖子。该杂志虽然秒拒多，但是审稿很效率，审稿人和编辑给的意见很中肯很有用，小修回去后还送了外审，等的我寝食难安，一天看三遍，送外审一个月左右后接收。提供完整的审稿时间记录，供大家参考。 Initial Date Submitted 28 2021 Editor Assigned 29 Jun 2021 Reviewers Assigned 03 Jul 2021 Under review 05 Jul 2021 Minor Revise Needed 28 Jul 2021 Revision Submitted 06 Aug 2021 Editor Assigned 07 Aug 2021 Reviewers Assigned 07 Aug 2021 Under review 09 Aug 2021 Accept 07 Sep 2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11a25527952, createdName=ms2000001011742244, createdTime=Wed Sep 08 00:33:23 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058585, encodeId=484810585850c, content=偏重的研究方向：肿瘤学;THERAPY;肿瘤 经验分享：大佬们，我10.1提交的，现在还在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210316/01c818a509864954848848a9dbd3a97d/253e9da10f88444a8866a1083d453c73.jpg, createdBy=31d51967896, createdName=小满爱米粒儿, createdTime=Fri Oct 08 12:45:51 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062115, encodeId=fdbc1062115e5, content=这个是非OA期刊吧，我看费用指南上写的APC费还挺贵，但是可以选择传统投稿方式（不需要APC费），但是我投稿时没看到非OA选项啊，请问这个APC费用是怎么回事啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18225625185, createdName=ms7000001551799699, createdTime=Tue Oct 19 23:14:01 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199964, encodeId=528e1199964a6, content=偏重的研究方向：肿瘤 经验分享：求助！请问需要推荐审稿人吗?咋推荐啊都不了解, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09645143875, createdName=幸运儿就是我, createdTime=Sun Mar 06 18:48:35 CST 2022, time=2022-03-06, status=1, ipAttribution=)]

2022-05-14 minni

偏重的研究方向：肿瘤
经验分享：请问各位大神，这篇杂志投meta分析的话需要注册号吗

29 0

[GetPortalCommentsPageByObjectIdResponse(id=1219605, encodeId=5ae912196054d, content=偏重的研究方向：肿瘤 经验分享：请问各位大神，这篇杂志投meta分析的话需要注册号吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e130109651, createdName=minni, createdTime=Sat May 14 16:11:07 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217427, encodeId=7d5f121e42755, content=求教：第一次投稿，小白一个，请问点击提交手稿后提示“'Submit a Manuscript' is not available for this publication.”，还是我投的地方不对，请赐教，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80564692906, createdName=945590468, createdTime=Fri May 06 20:49:27 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586545, encodeId=12ab5865454a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：写的一篇meta分析，2019年12月26日投稿，2020年1月15日一审审回，送了一个审稿人，提了一个相对容易点的问题，编辑给了大修。然后因为疫情耽搁了一个多月，最终在3月6号修回，第二天就送审了，3月10号收到接收信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/2686ccce883b2b8223b954905ff32d1e.jpg, createdBy=8f352558772, createdName=Ultraviolet, createdTime=Fri Mar 13 20:40:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212690, encodeId=6a6d121269005, content=能麻烦问一下这个提交的格式么还有这个期刊算sm a l l size journal 还是large 参考文献用什么格式呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7db88111196, createdName=ms6000001992460971, createdTime=Tue Apr 19 22:16:08 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212726, encodeId=581d1212e26e5, content=请问在哪里看目前有多少文章 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99298116595, createdName=ms5000000202400576, createdTime=Wed Apr 20 01:27:48 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209566, encodeId=d64e120956675, content=请问大佬们，为什么我的稿件投出去被秒退，我按照了guidline的操作，正文word，补充文件PDF，还没有到编辑那里就被退了…哭了…求教大佬……呜呜呜……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07b06478899, createdName=ms8000000732418295, createdTime=Fri Apr 08 14:43:40 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015523, encodeId=ddce1015523c2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：经验分享：这是我第一篇SCI，终于接收，想写一个分享帖子。该杂志虽然秒拒多，但是审稿很效率，审稿人和编辑给的意见很中肯很有用，小修回去后还送了外审，等的我寝食难安，一天看三遍，送外审一个月左右后接收。提供完整的审稿时间记录，供大家参考。 Initial Date Submitted 28 2021 Editor Assigned 29 Jun 2021 Reviewers Assigned 03 Jul 2021 Under review 05 Jul 2021 Minor Revise Needed 28 Jul 2021 Revision Submitted 06 Aug 2021 Editor Assigned 07 Aug 2021 Reviewers Assigned 07 Aug 2021 Under review 09 Aug 2021 Accept 07 Sep 2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11a25527952, createdName=ms2000001011742244, createdTime=Wed Sep 08 00:33:23 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058585, encodeId=484810585850c, content=偏重的研究方向：肿瘤学;THERAPY;肿瘤 经验分享：大佬们，我10.1提交的，现在还在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210316/01c818a509864954848848a9dbd3a97d/253e9da10f88444a8866a1083d453c73.jpg, createdBy=31d51967896, createdName=小满爱米粒儿, createdTime=Fri Oct 08 12:45:51 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062115, encodeId=fdbc1062115e5, content=这个是非OA期刊吧，我看费用指南上写的APC费还挺贵，但是可以选择传统投稿方式（不需要APC费），但是我投稿时没看到非OA选项啊，请问这个APC费用是怎么回事啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18225625185, createdName=ms7000001551799699, createdTime=Tue Oct 19 23:14:01 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199964, encodeId=528e1199964a6, content=偏重的研究方向：肿瘤 经验分享：求助！请问需要推荐审稿人吗?咋推荐啊都不了解, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09645143875, createdName=幸运儿就是我, createdTime=Sun Mar 06 18:48:35 CST 2022, time=2022-03-06, status=1, ipAttribution=)]

2022-05-06 945590468

求教：第一次投稿，小白一个，请问点击提交手稿后提示“'Submit a Manuscript' is not available for this publication.”，还是我投的地方不对，请赐教，谢谢！

24 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1219605, encodeId=5ae912196054d, content=偏重的研究方向：肿瘤 经验分享：请问各位大神，这篇杂志投meta分析的话需要注册号吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e130109651, createdName=minni, createdTime=Sat May 14 16:11:07 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217427, encodeId=7d5f121e42755, content=求教：第一次投稿，小白一个，请问点击提交手稿后提示“'Submit a Manuscript' is not available for this publication.”，还是我投的地方不对，请赐教，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80564692906, createdName=945590468, createdTime=Fri May 06 20:49:27 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586545, encodeId=12ab5865454a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：写的一篇meta分析，2019年12月26日投稿，2020年1月15日一审审回，送了一个审稿人，提了一个相对容易点的问题，编辑给了大修。然后因为疫情耽搁了一个多月，最终在3月6号修回，第二天就送审了，3月10号收到接收信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/2686ccce883b2b8223b954905ff32d1e.jpg, createdBy=8f352558772, createdName=Ultraviolet, createdTime=Fri Mar 13 20:40:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212690, encodeId=6a6d121269005, content=能麻烦问一下这个提交的格式么还有这个期刊算sm a l l size journal 还是large 参考文献用什么格式呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7db88111196, createdName=ms6000001992460971, createdTime=Tue Apr 19 22:16:08 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212726, encodeId=581d1212e26e5, content=请问在哪里看目前有多少文章 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99298116595, createdName=ms5000000202400576, createdTime=Wed Apr 20 01:27:48 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209566, encodeId=d64e120956675, content=请问大佬们，为什么我的稿件投出去被秒退，我按照了guidline的操作，正文word，补充文件PDF，还没有到编辑那里就被退了…哭了…求教大佬……呜呜呜……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07b06478899, createdName=ms8000000732418295, createdTime=Fri Apr 08 14:43:40 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015523, encodeId=ddce1015523c2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：经验分享：这是我第一篇SCI，终于接收，想写一个分享帖子。该杂志虽然秒拒多，但是审稿很效率，审稿人和编辑给的意见很中肯很有用，小修回去后还送了外审，等的我寝食难安，一天看三遍，送外审一个月左右后接收。提供完整的审稿时间记录，供大家参考。 Initial Date Submitted 28 2021 Editor Assigned 29 Jun 2021 Reviewers Assigned 03 Jul 2021 Under review 05 Jul 2021 Minor Revise Needed 28 Jul 2021 Revision Submitted 06 Aug 2021 Editor Assigned 07 Aug 2021 Reviewers Assigned 07 Aug 2021 Under review 09 Aug 2021 Accept 07 Sep 2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11a25527952, createdName=ms2000001011742244, createdTime=Wed Sep 08 00:33:23 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058585, encodeId=484810585850c, content=偏重的研究方向：肿瘤学;THERAPY;肿瘤 经验分享：大佬们，我10.1提交的，现在还在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210316/01c818a509864954848848a9dbd3a97d/253e9da10f88444a8866a1083d453c73.jpg, createdBy=31d51967896, createdName=小满爱米粒儿, createdTime=Fri Oct 08 12:45:51 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062115, encodeId=fdbc1062115e5, content=这个是非OA期刊吧，我看费用指南上写的APC费还挺贵，但是可以选择传统投稿方式（不需要APC费），但是我投稿时没看到非OA选项啊，请问这个APC费用是怎么回事啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18225625185, createdName=ms7000001551799699, createdTime=Tue Oct 19 23:14:01 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199964, encodeId=528e1199964a6, content=偏重的研究方向：肿瘤 经验分享：求助！请问需要推荐审稿人吗?咋推荐啊都不了解, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09645143875, createdName=幸运儿就是我, createdTime=Sun Mar 06 18:48:35 CST 2022, time=2022-03-06, status=1, ipAttribution=)]

2020-03-13 Ultraviolet

审稿速度:1.0 | 投稿命中率:75.0
经验分享：写的一篇meta分析，2019年12月26日投稿，2020年1月15日一审审回，送了一个审稿人，提了一个相对容易点的问题，编辑给了大修。然后因为疫情耽搁了一个多月，最终在3月6号修回，第二天就送审了，3月10号收到接收信。

172 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1219605, encodeId=5ae912196054d, content=偏重的研究方向：肿瘤 经验分享：请问各位大神，这篇杂志投meta分析的话需要注册号吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e130109651, createdName=minni, createdTime=Sat May 14 16:11:07 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217427, encodeId=7d5f121e42755, content=求教：第一次投稿，小白一个，请问点击提交手稿后提示“'Submit a Manuscript' is not available for this publication.”，还是我投的地方不对，请赐教，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80564692906, createdName=945590468, createdTime=Fri May 06 20:49:27 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586545, encodeId=12ab5865454a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：写的一篇meta分析，2019年12月26日投稿，2020年1月15日一审审回，送了一个审稿人，提了一个相对容易点的问题，编辑给了大修。然后因为疫情耽搁了一个多月，最终在3月6号修回，第二天就送审了，3月10号收到接收信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/2686ccce883b2b8223b954905ff32d1e.jpg, createdBy=8f352558772, createdName=Ultraviolet, createdTime=Fri Mar 13 20:40:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212690, encodeId=6a6d121269005, content=能麻烦问一下这个提交的格式么还有这个期刊算sm a l l size journal 还是large 参考文献用什么格式呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7db88111196, createdName=ms6000001992460971, createdTime=Tue Apr 19 22:16:08 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212726, encodeId=581d1212e26e5, content=请问在哪里看目前有多少文章 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99298116595, createdName=ms5000000202400576, createdTime=Wed Apr 20 01:27:48 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209566, encodeId=d64e120956675, content=请问大佬们，为什么我的稿件投出去被秒退，我按照了guidline的操作，正文word，补充文件PDF，还没有到编辑那里就被退了…哭了…求教大佬……呜呜呜……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07b06478899, createdName=ms8000000732418295, createdTime=Fri Apr 08 14:43:40 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015523, encodeId=ddce1015523c2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：经验分享：这是我第一篇SCI，终于接收，想写一个分享帖子。该杂志虽然秒拒多，但是审稿很效率，审稿人和编辑给的意见很中肯很有用，小修回去后还送了外审，等的我寝食难安，一天看三遍，送外审一个月左右后接收。提供完整的审稿时间记录，供大家参考。 Initial Date Submitted 28 2021 Editor Assigned 29 Jun 2021 Reviewers Assigned 03 Jul 2021 Under review 05 Jul 2021 Minor Revise Needed 28 Jul 2021 Revision Submitted 06 Aug 2021 Editor Assigned 07 Aug 2021 Reviewers Assigned 07 Aug 2021 Under review 09 Aug 2021 Accept 07 Sep 2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11a25527952, createdName=ms2000001011742244, createdTime=Wed Sep 08 00:33:23 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058585, encodeId=484810585850c, content=偏重的研究方向：肿瘤学;THERAPY;肿瘤 经验分享：大佬们，我10.1提交的，现在还在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210316/01c818a509864954848848a9dbd3a97d/253e9da10f88444a8866a1083d453c73.jpg, createdBy=31d51967896, createdName=小满爱米粒儿, createdTime=Fri Oct 08 12:45:51 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062115, encodeId=fdbc1062115e5, content=这个是非OA期刊吧，我看费用指南上写的APC费还挺贵，但是可以选择传统投稿方式（不需要APC费），但是我投稿时没看到非OA选项啊，请问这个APC费用是怎么回事啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18225625185, createdName=ms7000001551799699, createdTime=Tue Oct 19 23:14:01 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199964, encodeId=528e1199964a6, content=偏重的研究方向：肿瘤 经验分享：求助！请问需要推荐审稿人吗?咋推荐啊都不了解, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09645143875, createdName=幸运儿就是我, createdTime=Sun Mar 06 18:48:35 CST 2022, time=2022-03-06, status=1, ipAttribution=)]

2022-04-19 ms6000001992460971

能麻烦问一下这个提交的格式么还有这个期刊算sm a l l size journal 还是large 参考文献用什么格式呀

45 0

[GetPortalCommentsPageByObjectIdResponse(id=1219605, encodeId=5ae912196054d, content=偏重的研究方向：肿瘤 经验分享：请问各位大神，这篇杂志投meta分析的话需要注册号吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e130109651, createdName=minni, createdTime=Sat May 14 16:11:07 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217427, encodeId=7d5f121e42755, content=求教：第一次投稿，小白一个，请问点击提交手稿后提示“'Submit a Manuscript' is not available for this publication.”，还是我投的地方不对，请赐教，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80564692906, createdName=945590468, createdTime=Fri May 06 20:49:27 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586545, encodeId=12ab5865454a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：写的一篇meta分析，2019年12月26日投稿，2020年1月15日一审审回，送了一个审稿人，提了一个相对容易点的问题，编辑给了大修。然后因为疫情耽搁了一个多月，最终在3月6号修回，第二天就送审了，3月10号收到接收信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/2686ccce883b2b8223b954905ff32d1e.jpg, createdBy=8f352558772, createdName=Ultraviolet, createdTime=Fri Mar 13 20:40:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212690, encodeId=6a6d121269005, content=能麻烦问一下这个提交的格式么还有这个期刊算sm a l l size journal 还是large 参考文献用什么格式呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7db88111196, createdName=ms6000001992460971, createdTime=Tue Apr 19 22:16:08 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212726, encodeId=581d1212e26e5, content=请问在哪里看目前有多少文章 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99298116595, createdName=ms5000000202400576, createdTime=Wed Apr 20 01:27:48 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209566, encodeId=d64e120956675, content=请问大佬们，为什么我的稿件投出去被秒退，我按照了guidline的操作，正文word，补充文件PDF，还没有到编辑那里就被退了…哭了…求教大佬……呜呜呜……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07b06478899, createdName=ms8000000732418295, createdTime=Fri Apr 08 14:43:40 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015523, encodeId=ddce1015523c2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：经验分享：这是我第一篇SCI，终于接收，想写一个分享帖子。该杂志虽然秒拒多，但是审稿很效率，审稿人和编辑给的意见很中肯很有用，小修回去后还送了外审，等的我寝食难安，一天看三遍，送外审一个月左右后接收。提供完整的审稿时间记录，供大家参考。 Initial Date Submitted 28 2021 Editor Assigned 29 Jun 2021 Reviewers Assigned 03 Jul 2021 Under review 05 Jul 2021 Minor Revise Needed 28 Jul 2021 Revision Submitted 06 Aug 2021 Editor Assigned 07 Aug 2021 Reviewers Assigned 07 Aug 2021 Under review 09 Aug 2021 Accept 07 Sep 2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11a25527952, createdName=ms2000001011742244, createdTime=Wed Sep 08 00:33:23 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058585, encodeId=484810585850c, content=偏重的研究方向：肿瘤学;THERAPY;肿瘤 经验分享：大佬们，我10.1提交的，现在还在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210316/01c818a509864954848848a9dbd3a97d/253e9da10f88444a8866a1083d453c73.jpg, createdBy=31d51967896, createdName=小满爱米粒儿, createdTime=Fri Oct 08 12:45:51 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062115, encodeId=fdbc1062115e5, content=这个是非OA期刊吧，我看费用指南上写的APC费还挺贵，但是可以选择传统投稿方式（不需要APC费），但是我投稿时没看到非OA选项啊，请问这个APC费用是怎么回事啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18225625185, createdName=ms7000001551799699, createdTime=Tue Oct 19 23:14:01 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199964, encodeId=528e1199964a6, content=偏重的研究方向：肿瘤 经验分享：求助！请问需要推荐审稿人吗?咋推荐啊都不了解, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09645143875, createdName=幸运儿就是我, createdTime=Sun Mar 06 18:48:35 CST 2022, time=2022-03-06, status=1, ipAttribution=)]

2022-04-20 ms5000000202400576

请问在哪里看目前有多少文章

27 0

[GetPortalCommentsPageByObjectIdResponse(id=1219605, encodeId=5ae912196054d, content=偏重的研究方向：肿瘤 经验分享：请问各位大神，这篇杂志投meta分析的话需要注册号吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e130109651, createdName=minni, createdTime=Sat May 14 16:11:07 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217427, encodeId=7d5f121e42755, content=求教：第一次投稿，小白一个，请问点击提交手稿后提示“'Submit a Manuscript' is not available for this publication.”，还是我投的地方不对，请赐教，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80564692906, createdName=945590468, createdTime=Fri May 06 20:49:27 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586545, encodeId=12ab5865454a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：写的一篇meta分析，2019年12月26日投稿，2020年1月15日一审审回，送了一个审稿人，提了一个相对容易点的问题，编辑给了大修。然后因为疫情耽搁了一个多月，最终在3月6号修回，第二天就送审了，3月10号收到接收信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/2686ccce883b2b8223b954905ff32d1e.jpg, createdBy=8f352558772, createdName=Ultraviolet, createdTime=Fri Mar 13 20:40:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212690, encodeId=6a6d121269005, content=能麻烦问一下这个提交的格式么还有这个期刊算sm a l l size journal 还是large 参考文献用什么格式呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7db88111196, createdName=ms6000001992460971, createdTime=Tue Apr 19 22:16:08 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212726, encodeId=581d1212e26e5, content=请问在哪里看目前有多少文章 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99298116595, createdName=ms5000000202400576, createdTime=Wed Apr 20 01:27:48 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209566, encodeId=d64e120956675, content=请问大佬们，为什么我的稿件投出去被秒退，我按照了guidline的操作，正文word，补充文件PDF，还没有到编辑那里就被退了…哭了…求教大佬……呜呜呜……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07b06478899, createdName=ms8000000732418295, createdTime=Fri Apr 08 14:43:40 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015523, encodeId=ddce1015523c2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：经验分享：这是我第一篇SCI，终于接收，想写一个分享帖子。该杂志虽然秒拒多，但是审稿很效率，审稿人和编辑给的意见很中肯很有用，小修回去后还送了外审，等的我寝食难安，一天看三遍，送外审一个月左右后接收。提供完整的审稿时间记录，供大家参考。 Initial Date Submitted 28 2021 Editor Assigned 29 Jun 2021 Reviewers Assigned 03 Jul 2021 Under review 05 Jul 2021 Minor Revise Needed 28 Jul 2021 Revision Submitted 06 Aug 2021 Editor Assigned 07 Aug 2021 Reviewers Assigned 07 Aug 2021 Under review 09 Aug 2021 Accept 07 Sep 2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11a25527952, createdName=ms2000001011742244, createdTime=Wed Sep 08 00:33:23 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058585, encodeId=484810585850c, content=偏重的研究方向：肿瘤学;THERAPY;肿瘤 经验分享：大佬们，我10.1提交的，现在还在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210316/01c818a509864954848848a9dbd3a97d/253e9da10f88444a8866a1083d453c73.jpg, createdBy=31d51967896, createdName=小满爱米粒儿, createdTime=Fri Oct 08 12:45:51 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062115, encodeId=fdbc1062115e5, content=这个是非OA期刊吧，我看费用指南上写的APC费还挺贵，但是可以选择传统投稿方式（不需要APC费），但是我投稿时没看到非OA选项啊，请问这个APC费用是怎么回事啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18225625185, createdName=ms7000001551799699, createdTime=Tue Oct 19 23:14:01 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199964, encodeId=528e1199964a6, content=偏重的研究方向：肿瘤 经验分享：求助！请问需要推荐审稿人吗?咋推荐啊都不了解, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09645143875, createdName=幸运儿就是我, createdTime=Sun Mar 06 18:48:35 CST 2022, time=2022-03-06, status=1, ipAttribution=)]

2022-04-08 ms8000000732418295

请问大佬们，为什么我的稿件投出去被秒退，我按照了guidline的操作，正文word，补充文件PDF，还没有到编辑那里就被退了…哭了…求教大佬……呜呜呜……

27 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1219605, encodeId=5ae912196054d, content=偏重的研究方向：肿瘤 经验分享：请问各位大神，这篇杂志投meta分析的话需要注册号吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e130109651, createdName=minni, createdTime=Sat May 14 16:11:07 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217427, encodeId=7d5f121e42755, content=求教：第一次投稿，小白一个，请问点击提交手稿后提示“'Submit a Manuscript' is not available for this publication.”，还是我投的地方不对，请赐教，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80564692906, createdName=945590468, createdTime=Fri May 06 20:49:27 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586545, encodeId=12ab5865454a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：写的一篇meta分析，2019年12月26日投稿，2020年1月15日一审审回，送了一个审稿人，提了一个相对容易点的问题，编辑给了大修。然后因为疫情耽搁了一个多月，最终在3月6号修回，第二天就送审了，3月10号收到接收信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/2686ccce883b2b8223b954905ff32d1e.jpg, createdBy=8f352558772, createdName=Ultraviolet, createdTime=Fri Mar 13 20:40:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212690, encodeId=6a6d121269005, content=能麻烦问一下这个提交的格式么还有这个期刊算sm a l l size journal 还是large 参考文献用什么格式呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7db88111196, createdName=ms6000001992460971, createdTime=Tue Apr 19 22:16:08 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212726, encodeId=581d1212e26e5, content=请问在哪里看目前有多少文章 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99298116595, createdName=ms5000000202400576, createdTime=Wed Apr 20 01:27:48 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209566, encodeId=d64e120956675, content=请问大佬们，为什么我的稿件投出去被秒退，我按照了guidline的操作，正文word，补充文件PDF，还没有到编辑那里就被退了…哭了…求教大佬……呜呜呜……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07b06478899, createdName=ms8000000732418295, createdTime=Fri Apr 08 14:43:40 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015523, encodeId=ddce1015523c2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：经验分享：这是我第一篇SCI，终于接收，想写一个分享帖子。该杂志虽然秒拒多，但是审稿很效率，审稿人和编辑给的意见很中肯很有用，小修回去后还送了外审，等的我寝食难安，一天看三遍，送外审一个月左右后接收。提供完整的审稿时间记录，供大家参考。 Initial Date Submitted 28 2021 Editor Assigned 29 Jun 2021 Reviewers Assigned 03 Jul 2021 Under review 05 Jul 2021 Minor Revise Needed 28 Jul 2021 Revision Submitted 06 Aug 2021 Editor Assigned 07 Aug 2021 Reviewers Assigned 07 Aug 2021 Under review 09 Aug 2021 Accept 07 Sep 2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11a25527952, createdName=ms2000001011742244, createdTime=Wed Sep 08 00:33:23 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058585, encodeId=484810585850c, content=偏重的研究方向：肿瘤学;THERAPY;肿瘤 经验分享：大佬们，我10.1提交的，现在还在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210316/01c818a509864954848848a9dbd3a97d/253e9da10f88444a8866a1083d453c73.jpg, createdBy=31d51967896, createdName=小满爱米粒儿, createdTime=Fri Oct 08 12:45:51 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062115, encodeId=fdbc1062115e5, content=这个是非OA期刊吧，我看费用指南上写的APC费还挺贵，但是可以选择传统投稿方式（不需要APC费），但是我投稿时没看到非OA选项啊，请问这个APC费用是怎么回事啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18225625185, createdName=ms7000001551799699, createdTime=Tue Oct 19 23:14:01 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199964, encodeId=528e1199964a6, content=偏重的研究方向：肿瘤 经验分享：求助！请问需要推荐审稿人吗?咋推荐啊都不了解, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09645143875, createdName=幸运儿就是我, createdTime=Sun Mar 06 18:48:35 CST 2022, time=2022-03-06, status=1, ipAttribution=)]

2021-09-08 ms2000001011742244

审稿速度:1.0 | 投稿命中率:50.0
经验分享：经验分享：这是我第一篇SCI，终于接收，想写一个分享帖子。该杂志虽然秒拒多，但是审稿很效率，审稿人和编辑给的意见很中肯很有用，小修回去后还送了外审，等的我寝食难安，一天看三遍，送外审一个月左右后接收。提供完整的审稿时间记录，供大家参考。
Initial Date Submitted 28 2021
Editor Assigned 29 Jun 2021
Reviewers Assigned 03 Jul 2021
Under review 05 Jul 2021
Minor Revise Needed 28 Jul 2021
Revision Submitted 06 Aug 2021
Editor Assigned 07 Aug 2021
Reviewers Assigned 07 Aug 2021
Under review 09 Aug 2021
Accept 07 Sep 2021

75 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1219605, encodeId=5ae912196054d, content=偏重的研究方向：肿瘤 经验分享：请问各位大神，这篇杂志投meta分析的话需要注册号吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e130109651, createdName=minni, createdTime=Sat May 14 16:11:07 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217427, encodeId=7d5f121e42755, content=求教：第一次投稿，小白一个，请问点击提交手稿后提示“'Submit a Manuscript' is not available for this publication.”，还是我投的地方不对，请赐教，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80564692906, createdName=945590468, createdTime=Fri May 06 20:49:27 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586545, encodeId=12ab5865454a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：写的一篇meta分析，2019年12月26日投稿，2020年1月15日一审审回，送了一个审稿人，提了一个相对容易点的问题，编辑给了大修。然后因为疫情耽搁了一个多月，最终在3月6号修回，第二天就送审了，3月10号收到接收信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/2686ccce883b2b8223b954905ff32d1e.jpg, createdBy=8f352558772, createdName=Ultraviolet, createdTime=Fri Mar 13 20:40:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212690, encodeId=6a6d121269005, content=能麻烦问一下这个提交的格式么还有这个期刊算sm a l l size journal 还是large 参考文献用什么格式呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7db88111196, createdName=ms6000001992460971, createdTime=Tue Apr 19 22:16:08 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212726, encodeId=581d1212e26e5, content=请问在哪里看目前有多少文章 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99298116595, createdName=ms5000000202400576, createdTime=Wed Apr 20 01:27:48 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209566, encodeId=d64e120956675, content=请问大佬们，为什么我的稿件投出去被秒退，我按照了guidline的操作，正文word，补充文件PDF，还没有到编辑那里就被退了…哭了…求教大佬……呜呜呜……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07b06478899, createdName=ms8000000732418295, createdTime=Fri Apr 08 14:43:40 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015523, encodeId=ddce1015523c2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：经验分享：这是我第一篇SCI，终于接收，想写一个分享帖子。该杂志虽然秒拒多，但是审稿很效率，审稿人和编辑给的意见很中肯很有用，小修回去后还送了外审，等的我寝食难安，一天看三遍，送外审一个月左右后接收。提供完整的审稿时间记录，供大家参考。 Initial Date Submitted 28 2021 Editor Assigned 29 Jun 2021 Reviewers Assigned 03 Jul 2021 Under review 05 Jul 2021 Minor Revise Needed 28 Jul 2021 Revision Submitted 06 Aug 2021 Editor Assigned 07 Aug 2021 Reviewers Assigned 07 Aug 2021 Under review 09 Aug 2021 Accept 07 Sep 2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11a25527952, createdName=ms2000001011742244, createdTime=Wed Sep 08 00:33:23 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058585, encodeId=484810585850c, content=偏重的研究方向：肿瘤学;THERAPY;肿瘤 经验分享：大佬们，我10.1提交的，现在还在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210316/01c818a509864954848848a9dbd3a97d/253e9da10f88444a8866a1083d453c73.jpg, createdBy=31d51967896, createdName=小满爱米粒儿, createdTime=Fri Oct 08 12:45:51 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062115, encodeId=fdbc1062115e5, content=这个是非OA期刊吧，我看费用指南上写的APC费还挺贵，但是可以选择传统投稿方式（不需要APC费），但是我投稿时没看到非OA选项啊，请问这个APC费用是怎么回事啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18225625185, createdName=ms7000001551799699, createdTime=Tue Oct 19 23:14:01 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199964, encodeId=528e1199964a6, content=偏重的研究方向：肿瘤 经验分享：求助！请问需要推荐审稿人吗?咋推荐啊都不了解, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09645143875, createdName=幸运儿就是我, createdTime=Sun Mar 06 18:48:35 CST 2022, time=2022-03-06, status=1, ipAttribution=)]

2021-10-08 小满爱米粒儿

偏重的研究方向：肿瘤学;THERAPY;肿瘤
经验分享：大佬们，我10.1提交的，现在还在editor assigned

75 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1219605, encodeId=5ae912196054d, content=偏重的研究方向：肿瘤 经验分享：请问各位大神，这篇杂志投meta分析的话需要注册号吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e130109651, createdName=minni, createdTime=Sat May 14 16:11:07 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217427, encodeId=7d5f121e42755, content=求教：第一次投稿，小白一个，请问点击提交手稿后提示“'Submit a Manuscript' is not available for this publication.”，还是我投的地方不对，请赐教，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80564692906, createdName=945590468, createdTime=Fri May 06 20:49:27 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586545, encodeId=12ab5865454a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：写的一篇meta分析，2019年12月26日投稿，2020年1月15日一审审回，送了一个审稿人，提了一个相对容易点的问题，编辑给了大修。然后因为疫情耽搁了一个多月，最终在3月6号修回，第二天就送审了，3月10号收到接收信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/2686ccce883b2b8223b954905ff32d1e.jpg, createdBy=8f352558772, createdName=Ultraviolet, createdTime=Fri Mar 13 20:40:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212690, encodeId=6a6d121269005, content=能麻烦问一下这个提交的格式么还有这个期刊算sm a l l size journal 还是large 参考文献用什么格式呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7db88111196, createdName=ms6000001992460971, createdTime=Tue Apr 19 22:16:08 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212726, encodeId=581d1212e26e5, content=请问在哪里看目前有多少文章 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99298116595, createdName=ms5000000202400576, createdTime=Wed Apr 20 01:27:48 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209566, encodeId=d64e120956675, content=请问大佬们，为什么我的稿件投出去被秒退，我按照了guidline的操作，正文word，补充文件PDF，还没有到编辑那里就被退了…哭了…求教大佬……呜呜呜……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07b06478899, createdName=ms8000000732418295, createdTime=Fri Apr 08 14:43:40 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015523, encodeId=ddce1015523c2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：经验分享：这是我第一篇SCI，终于接收，想写一个分享帖子。该杂志虽然秒拒多，但是审稿很效率，审稿人和编辑给的意见很中肯很有用，小修回去后还送了外审，等的我寝食难安，一天看三遍，送外审一个月左右后接收。提供完整的审稿时间记录，供大家参考。 Initial Date Submitted 28 2021 Editor Assigned 29 Jun 2021 Reviewers Assigned 03 Jul 2021 Under review 05 Jul 2021 Minor Revise Needed 28 Jul 2021 Revision Submitted 06 Aug 2021 Editor Assigned 07 Aug 2021 Reviewers Assigned 07 Aug 2021 Under review 09 Aug 2021 Accept 07 Sep 2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11a25527952, createdName=ms2000001011742244, createdTime=Wed Sep 08 00:33:23 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058585, encodeId=484810585850c, content=偏重的研究方向：肿瘤学;THERAPY;肿瘤 经验分享：大佬们，我10.1提交的，现在还在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210316/01c818a509864954848848a9dbd3a97d/253e9da10f88444a8866a1083d453c73.jpg, createdBy=31d51967896, createdName=小满爱米粒儿, createdTime=Fri Oct 08 12:45:51 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062115, encodeId=fdbc1062115e5, content=这个是非OA期刊吧，我看费用指南上写的APC费还挺贵，但是可以选择传统投稿方式（不需要APC费），但是我投稿时没看到非OA选项啊，请问这个APC费用是怎么回事啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18225625185, createdName=ms7000001551799699, createdTime=Tue Oct 19 23:14:01 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199964, encodeId=528e1199964a6, content=偏重的研究方向：肿瘤 经验分享：求助！请问需要推荐审稿人吗?咋推荐啊都不了解, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09645143875, createdName=幸运儿就是我, createdTime=Sun Mar 06 18:48:35 CST 2022, time=2022-03-06, status=1, ipAttribution=)]

2021-10-19 ms7000001551799699

这个是非OA期刊吧，我看费用指南上写的APC费还挺贵，但是可以选择传统投稿方式（不需要APC费），但是我投稿时没看到非OA选项啊，请问这个APC费用是怎么回事啊？

55 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1219605, encodeId=5ae912196054d, content=偏重的研究方向：肿瘤 经验分享：请问各位大神，这篇杂志投meta分析的话需要注册号吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e130109651, createdName=minni, createdTime=Sat May 14 16:11:07 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217427, encodeId=7d5f121e42755, content=求教：第一次投稿，小白一个，请问点击提交手稿后提示“'Submit a Manuscript' is not available for this publication.”，还是我投的地方不对，请赐教，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80564692906, createdName=945590468, createdTime=Fri May 06 20:49:27 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586545, encodeId=12ab5865454a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：写的一篇meta分析，2019年12月26日投稿，2020年1月15日一审审回，送了一个审稿人，提了一个相对容易点的问题，编辑给了大修。然后因为疫情耽搁了一个多月，最终在3月6号修回，第二天就送审了，3月10号收到接收信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/2686ccce883b2b8223b954905ff32d1e.jpg, createdBy=8f352558772, createdName=Ultraviolet, createdTime=Fri Mar 13 20:40:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212690, encodeId=6a6d121269005, content=能麻烦问一下这个提交的格式么还有这个期刊算sm a l l size journal 还是large 参考文献用什么格式呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7db88111196, createdName=ms6000001992460971, createdTime=Tue Apr 19 22:16:08 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212726, encodeId=581d1212e26e5, content=请问在哪里看目前有多少文章 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99298116595, createdName=ms5000000202400576, createdTime=Wed Apr 20 01:27:48 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209566, encodeId=d64e120956675, content=请问大佬们，为什么我的稿件投出去被秒退，我按照了guidline的操作，正文word，补充文件PDF，还没有到编辑那里就被退了…哭了…求教大佬……呜呜呜……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07b06478899, createdName=ms8000000732418295, createdTime=Fri Apr 08 14:43:40 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015523, encodeId=ddce1015523c2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：经验分享：这是我第一篇SCI，终于接收，想写一个分享帖子。该杂志虽然秒拒多，但是审稿很效率，审稿人和编辑给的意见很中肯很有用，小修回去后还送了外审，等的我寝食难安，一天看三遍，送外审一个月左右后接收。提供完整的审稿时间记录，供大家参考。 Initial Date Submitted 28 2021 Editor Assigned 29 Jun 2021 Reviewers Assigned 03 Jul 2021 Under review 05 Jul 2021 Minor Revise Needed 28 Jul 2021 Revision Submitted 06 Aug 2021 Editor Assigned 07 Aug 2021 Reviewers Assigned 07 Aug 2021 Under review 09 Aug 2021 Accept 07 Sep 2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11a25527952, createdName=ms2000001011742244, createdTime=Wed Sep 08 00:33:23 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058585, encodeId=484810585850c, content=偏重的研究方向：肿瘤学;THERAPY;肿瘤 经验分享：大佬们，我10.1提交的，现在还在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210316/01c818a509864954848848a9dbd3a97d/253e9da10f88444a8866a1083d453c73.jpg, createdBy=31d51967896, createdName=小满爱米粒儿, createdTime=Fri Oct 08 12:45:51 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062115, encodeId=fdbc1062115e5, content=这个是非OA期刊吧，我看费用指南上写的APC费还挺贵，但是可以选择传统投稿方式（不需要APC费），但是我投稿时没看到非OA选项啊，请问这个APC费用是怎么回事啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18225625185, createdName=ms7000001551799699, createdTime=Tue Oct 19 23:14:01 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199964, encodeId=528e1199964a6, content=偏重的研究方向：肿瘤 经验分享：求助！请问需要推荐审稿人吗?咋推荐啊都不了解, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09645143875, createdName=幸运儿就是我, createdTime=Sun Mar 06 18:48:35 CST 2022, time=2022-03-06, status=1, ipAttribution=)]

2022-03-06 幸运儿就是我

偏重的研究方向：肿瘤
经验分享：求助！请问需要推荐审稿人吗?咋推荐啊都不了解

21 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务